REQUEST A DEMO
Total
USD $0.00
Search more companies

Oktal Pharma D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Oktal Pharma D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Oktal Pharma D.O.O. Beograd is based in Serbia. The head office is in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on February 17, 2004. 53 (2023) employees currently work for Oktal Pharma D.O.O. Beograd. The company’s latest financial report indicates a net sales revenue increase of 27.17% in 2023. Its’ total assets recorded a growth of 17.7%. The enterprise’s net profit margin increased by 0.42% in 2023.

Headquarters
Viline Vode BB
Belgrade; Belgrade; Postal Code: www.oktal-pharma.rs

Contact Details: Purchase the Oktal Pharma D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Oktal Pharma D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Oktal Pharma D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Oktal Pharma D.O.O. Beograd report to view the information.
Incorporation Date:
February 17, 2004
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Oktal Pharma D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
27.17%
Total operating revenue
26.78%
Operating profit (EBIT)
17.22%
EBITDA
14.41%
Net Profit (Loss) for the Period
35.15%
Total assets
17.7%
Total equity
-2.26%
Operating Profit Margin (ROS)
-0.69%
Net Profit Margin
0.42%
Return on Equity (ROE)
8.24%
Debt to Equity Ratio
-1.35%
Quick Ratio
-0.51%
Cash Ratio
-0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?